Stock Fundamentals

Company Information

Company Name
Concentra Group Holdings Parent, Inc.
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYSE
ISIN: US20603L1026
CIK: 0002014596
CUSIP: 20603L102
Currency: USD
Full Time Employees: 9,967
Phone: 972 364 8000
Fiscal Year End: December
IPO Date: Jul 25, 2024
Description:

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Address:

5080 Spectrum Drive, Addison, TX, United States, 75001

Directors & Officers

Name Title Year Born
Mr. William Keith Newton CEO & Director 1963
Mr. Matthew T. DiCanio M.B.A. President & CFO 1983
Mr. John A. deLorimier Executive VP and Chief Information & Technology Officer 1960
Mr. Timothy F. Ryan Executive VP & Chief Legal Counsel 1961
Dr. John R. Anderson DO, FACOEM Executive VP & Chief Medical Officer 1950
Ms. Su Zan Nelson CPA Executive VP & Chief Accounting Officer 1964
Mr. Thomas A. Devasia Executive VP and Chief Marketing & Innovation Officer 1970
Ms. Danielle Kendall Executive VP & Chief People Officer 1969
Mr. Giovanni Gallara Executive VP & Chief Clinical Services Officer 1975
Mr. Michael A. Kosuth Executive VP & COO of East 1958

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 17.07M Mar 31, 2026 13.34% $0.01 -0.98%
T. Rowe Price Associates, Inc. 17.04M Mar 31, 2026 13.31% $0.04 1.15%
Vanguard Group Inc 12.60M Dec 31, 2025 9.85% $0.00 -4.55%
State Street Corp 4.60M Mar 31, 2026 3.60% $0.00 3.51%
Barrow Hanley Mewhinney & Strauss LLC 3.21M Mar 31, 2026 2.51% $0.23 79.03%
Dimensional Fund Advisors, Inc. 3.11M Mar 31, 2026 2.43% $0.01 4.87%
JPMorgan Chase & Co 3.02M Mar 31, 2026 2.36% $0.00 -19.46%
Geode Capital Management, LLC 2.93M Mar 31, 2026 2.29% $0.00 2.86%
Thrivent Financial For Lutherans 2.84M Mar 31, 2026 2.22% $0.12 -0.44%
Principal Financial Group Inc 2.67M Mar 31, 2026 2.09% $0.03 1.59%
Amvescap Plc. 2.67M Mar 31, 2026 2.08% $0.01 382.21%
T. Rowe Price Investment Management,Inc. 2.56M Mar 31, 2026 2.00% $0.04 -39.79%
NORGES BANK 2.21M Dec 31, 2025 1.72% $0.00 47.58%
Jennison Associates LLC 2.17M Mar 31, 2026 1.70% $0.03 195.80%
Charles Schwab Investment Management Inc 2.04M Mar 31, 2026 1.59% $0.01 -1.69%
Massachusetts Financial Services Company 1.37M Mar 31, 2026 1.07% $0.01 -25.03%
Northern Trust Corp 1.26M Mar 31, 2026 0.99% $0.00 2.14%
Citadel Advisors Llc 1.23M Mar 31, 2026 0.96% $0.00 -45.32%
Manufacturers Life Insurance Co 1.11M Mar 31, 2026 0.87% $0.02 -29.46%
Cramer Rosenthal McGlynn LLC 1.07M Mar 31, 2026 0.83% $1.68 -46.13%

Shares Statistics

Shares Outstanding: 127.96M
Shares Float: 114.24M
% Insiders: 1,072.80%
% Institutions: 8,791.80%
Short % Float: 3.10%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 T. Rowe Price Mid-Cap Value 7.52M 5.88% ▲ 0.00% Mar 31, 2026
2 T. Rowe Price US Mid-Cap Value Equity 7.52M 5.88% ▼ 0.36% Mar 31, 2026
3 iShares Core S&P Small-Cap ETF 7.27M 5.68% ▲ 0.02% Apr 30, 2026
4 T. Rowe Price U.S. Mid-Cap Val Eq Tr-D 4.74M 3.70% ▲ 6.86% Mar 31, 2026
5 Vanguard Total Stock Mkt Idx Inv 3.66M 2.86% ▲ 0.43% Apr 30, 2026
6 iShares Russell 2000 ETF 2.74M 2.14% ▲ 0.85% Apr 30, 2026
7 Vanguard Small Cap Index 2.67M 2.09% ▼ 0.16% Apr 30, 2026
8 Invesco Small Cap Value A 2.15M 1.68% ▲ 3.64% Mar 31, 2026
9 Thrivent Small Cap Stock A 1.86M 1.45% ▼ 0.04% Mar 31, 2026
10 Vanguard Small Cap Value Index Inv 1.71M 1.34% ▲ 0.72% Apr 30, 2026

Valuation Metrics

Enterprise Value: $5.29B
Trailing P/E: 18.05
Forward P/E: 16.72

Financial Highlights

Market Cap: $3.21B
EBITDA: $437.54M
P/E Ratio: $18.05
Book Value: $3.32
Dividend/Share: $0.25
Dividend Yield: 0.99%
Earnings/Share: $1.39
Profit Margin: 7.97%
Operating Margin: 17.01%
ROA (TTM): 7.98%
ROE (TTM): 47.00%
Revenue (TTM): $2.23B
Revenue/Share (TTM): $17.43
Earnings Growth (YOY): 29.40%
Revenue Growth (YOY): 13.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.14x 4.22x 0.86x 19.10x 4.06x
2024-12-31 1.42x 5.64x 0.88x 4.37x 4.22x
2023-12-31 1.07x 0.06x 0.53x 2.52x 0.21x
2022-12-31 1.02x 0.73x 0.57x 8.16x 2.14x
2021-12-31 N/A N/A N/A 8.48x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CON.US!